Maverick Medical AI

Company Overview

Snapshot

Founded in July 2017 by Yossi Shahak and Michael Brozino, Maverick Medical AI operates with 11–50 employees. The company has raised a total of $10.4M across 5 funding rounds from 10 investors.

Business overview

Maverick Medical AI is a commercial-stage company that develops an AI-based autodidactic and autonomous medical coding platform. Its core product, mCoder, utilizes advanced artificial intelligence and deep-learning technology to understand unstructured patient reports and autonomously convert them into medical codes for reimbursement claims. The platform serves the healthcare industry, specifically targeting healthcare providers and insurance companies, operating within the Health Tech & Life Sciences sector with a focus on digital healthcare and clinical workflow solutions.

Strategic signal

In August 2025, Infinx invested in Maverick Medical AI to integrate real-time autonomous medical coding into revenue cycle management. This strategic investment highlights the growing market demand for AI-driven solutions to enhance efficiency and accuracy in medical billing, positioning Maverick Medical AI as a key player in transforming healthcare administrative processes.

Company Intelligence Q&A

When did Maverick Medical AI close its seed investment round?

In March 2022, Maverick Medical AI closed a seed investment round, led by LionBird, to accelerate the development of its mCoder artificial intelligence platform for additional clinical domains.

When did Maverick Medical AI announce its first commercial deployment?

In September 2019, Maverick Medical AI announced its first commercial deployment at USHS Health System to automatically detect Medicare Advantage risk factors.

When did Michael Brozino join Maverick Medical AI?

In August 2020, Michael Brozino joined Maverick Medical AI as Co-founder and Chief Commercial Officer to bring clinical AI cognition technology to market.